Quality of Life, Overall Survival, and Costs of Cancer Drugs Approved Based on Surrogate Endpoints (Q88874590)
Jump to navigation
Jump to search
scientific article published on 01 February 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quality of Life, Overall Survival, and Costs of Cancer Drugs Approved Based on Surrogate Endpoints |
scientific article published on 01 February 2017 |
Statements
Quality of Life, Overall Survival, and Costs of Cancer Drugs Approved Based on Surrogate Endpoints (English)
Tracy Rupp
Diana Zuckerman
1 February 2017